Skip to main content
. 2017 Dec 6;4(4):215–221. doi: 10.1016/j.gendis.2017.10.003

Table 3.

Correlation of miR-122 and miR-224 level with clinical variables in CHC and HCC groups.

CHC group
HCC group
MiR-122
MiR-224
MiR-122
MiR-224
R P-value R P-value R P-value R P-value
AFP 0.7 <0.001 0.22 0.81 −0.66 <0.001 0.44 0.004
ALT 0.53 <0.001 −0.02 0.89 −0.67 <0.001 0.44 0.004
AST 0.57 <0.001 0.06 0.69 −0.61 <0.001 0.52 <0.001
ALP 0.47 0.002 −0.07 0.69 −0.66 <0.001 0.37 0.02
PC −0.56 <0.001 −0.01 0.95 0.55 <0.001 −0.46 0.002
PLT −0.44 0.005 0.08 0.62 −0.09 0.39 −0.16 0.32
Albumin −0.54 <0.001 −0.15 0.35 0.54 <0.001 −0.5 0.001
Bilirubin −0.15 0.36 −0.2 0.43 −0.03 0.41 0.02 0.92
Tumor Size −0.35 0.03 0.87 <0.001
MiR-122 0.04 0.81 −0.34 0.03
MiR-224 0.04 0.81 −0.34 0.033

AFP: alpha fetoprotein, ALT: alanine aminotransferase, AST: aspartate aminotransferase, ALP: alkaline phosphatase, PC: prothrombin concentration, PLT: platelets Count, CT: Computed tomography.